US Bancorp’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,687
Closed -$23K 4304
2022
Q3
$23K Hold
19,687
﹤0.01% 2961
2022
Q2
$36K Sell
19,687
-2,192
-10% -$4.01K ﹤0.01% 2764
2022
Q1
$44K Buy
21,879
+466
+2% +$937 ﹤0.01% 2691
2021
Q4
$59K Sell
21,413
-1,484
-6% -$4.09K ﹤0.01% 2558
2021
Q3
$103K Buy
22,897
+3,026
+15% +$13.6K ﹤0.01% 2286
2021
Q2
$115K Sell
19,871
-512
-3% -$2.96K ﹤0.01% 2230
2021
Q1
$143K Sell
20,383
-8,100
-28% -$56.8K ﹤0.01% 2074
2020
Q4
$137K Buy
28,483
+5,580
+24% +$26.8K ﹤0.01% 2048
2020
Q3
$133K Sell
22,903
-2,198
-9% -$12.8K ﹤0.01% 1945
2020
Q2
$170K Buy
25,101
+402
+2% +$2.72K ﹤0.01% 1836
2020
Q1
$157K Buy
24,699
+199
+0.8% +$1.27K ﹤0.01% 1758
2019
Q4
$256K Buy
24,500
+19,500
+390% +$204K ﹤0.01% 1708
2019
Q3
$20K Sell
5,000
-5,991
-55% -$24K ﹤0.01% 2853
2019
Q2
$164K Buy
10,991
+2,171
+25% +$32.4K ﹤0.01% 1927
2019
Q1
$219K Buy
8,820
+681
+8% +$16.9K ﹤0.01% 1769
2018
Q4
$146K Buy
8,139
+2,075
+34% +$37.2K ﹤0.01% 1922
2018
Q3
$178K Buy
6,064
+709
+13% +$20.8K ﹤0.01% 1929
2018
Q2
$243K Sell
5,355
-234
-4% -$10.6K ﹤0.01% 1774
2018
Q1
$296K Buy
5,589
+4,981
+819% +$264K ﹤0.01% 1671
2017
Q4
$41K Buy
608
+195
+47% +$13.2K ﹤0.01% 2689
2017
Q3
$34K Buy
413
+319
+339% +$26.3K ﹤0.01% 2724
2017
Q2
$8K Buy
94
+33
+54% +$2.81K ﹤0.01% 3121
2017
Q1
$4K Buy
+61
New +$4K ﹤0.01% 3283
2016
Q1
Sell
-1,059
Closed -$37K 3696
2015
Q4
$37K Buy
1,059
+289
+38% +$10.1K ﹤0.01% 2585
2015
Q3
$71K Sell
770
-764
-50% -$70.4K ﹤0.01% 2278
2015
Q2
$134K Buy
1,534
+66
+4% +$5.77K ﹤0.01% 1971
2015
Q1
$109K Buy
1,468
+92
+7% +$6.83K ﹤0.01% 2121
2014
Q4
$77K Buy
1,376
+393
+40% +$22K ﹤0.01% 2304
2014
Q3
$45K Buy
+983
New +$45K ﹤0.01% 2543